Open Beta
TREN
MetriLume
TREN

US marketsBDMD

SEC-sourced researchBeta

BDMD

Baird Medical Investment Holdings Ltd

Company comparison ↗

Data passport

CIK
0001982444
Exchange
Nasdaq
Business activity
Surgical & Medical Instruments & Apparatus · SIC 3841
Financial inputs
6/6
Filing date
Oct 1, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 31,457,908.0000 USD; December 2024: 37,037,108.0000 USD; December 2025: 22,537,016.0000 USD37M USD0 USD0December 2023December 2024December 2025
BDMD · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202331,457,908.0000Jul 27, 2026
December 202437,037,108.0000Jul 27, 2026
December 202522,537,016.0000Jul 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202522,537,016.0000-27,278,005.0000-1,344,032.000069,701,015.000038,477,473.0000Jul 27, 2026
December 202437,037,108.000012,453,369.0000-6,313,115.000077,962,870.000038,202,392.0000Jul 27, 2026
December 202331,457,908.000010,545,978.0000-1,019,964.0000——Jul 27, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

39/100
Profitability0
Growth11
Balance sheet45
Cash generation38
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$22.54MJan 1, 2025 – Dec 31, 2025Jul 27, 202620-F/A
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$37.04MJan 1, 2024 – Dec 31, 2024Jul 27, 202620-F/A
Net incomeNetIncomeLoss-$27.28MJan 1, 2025 – Dec 31, 2025Jul 27, 202620-F/A
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$1.34MJan 1, 2025 – Dec 31, 2025Jul 27, 202620-F/A
Total assetsAssets$69.7MDec 31, 2025Jul 27, 202620-F/A
Total liabilitiesLiabilities$38.48MDec 31, 2025Jul 27, 202620-F/A

New filings

Explore methodology ↗